You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 17, 2025

Claims for Patent: 9,180,125

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 9,180,125

Title:	Peripheral opioid receptor antagonists and uses thereof
Abstract:	The present invention provides a compound of formula I: wherein X−, R1, and R2 are as defined herein, and compositions thereof.
Inventor(s):	Nataliya BAZHINA, George Joseph Donato, III, Steven R. Fabian, John Lokhnauth, Sreenivasulu Megati, Charles Melucci, Christian Ofslager, Niketa Patel, Galen Radebaugh, Syed M. Shah, Jan Szeliga, Huyi Zhang, Tianmin Zhu
Assignee:	Wyeth LLC
Application Number:	US14/322,382
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,180,125
Patent Claims:	1. A composition comprising a compound of formula III: wherein A− is an anion of a Brønsted acid, wherein the composition is substantially free of tungsten, and wherein the composition comprises less than 190 ppm of a compound of formula II: wherein X− is an anion of a Brønsted acid. 2. The composition of claim 1, wherein the Brønsted acid is selected from the group consisting of a hydrogen halide, a carboxylic acid, a sulfonic acid, a sulfuric acid, and a phosphoric acid. 3. The composition of claim 1, wherein X− or A− is selected from the group consisting of chloride, bromide, iodide, fluoride, sulfate, bisulfate, tartrate, nitrate, citrate, bitartrate, carbonate, phosphate, malate, maleate, fumarate, sulfonate, methylsulfonate, formate, carboxylate, methylsulfate, trifluoroacetate, and succinate. 4. The composition of claim 3, wherein X− or A− is bromide. 5. The composition of claim 1, wherein the tungsten is present in an amount of less than about 60 parts per billion. 6. The composition of claim 1, wherein the compound of formula III is provided in a solution. 7. The composition of claim 6, wherein the solution comprises about 8 mg of the compound of formula III in about 0.4 mL water. 8. The composition of claim 7, wherein the compound of formula III is of formula III-1: 9. The composition of claim 6, wherein the solution comprises about 12 mg of the compound of formula III in about 0.6 mL water. 10. The composition of claim 9, wherein the compound of formula III is of formula III-1: 11. The composition of claim 1, wherein the compound of formula III is contained within a package that is substantially free of tungsten. 12. The composition of claim 11, wherein the package is selected from the group consisting of a syringe, a vial, and an ampoule. 13. The composition of claim 12, wherein the package is a syringe. 14. A method for treating a gastrointestinal disorder in a subject comprising administering the composition of claim 1. 15. The method of claim 14, wherein the gastrointestinal disorder is constipation. 16. The method of claim 15, wherein the constipation is opioid-induced. 17. The method of claim 14, wherein the subject receives opioids chronically. 18. The method of claim 14, wherein the subject is a cancer patient. 19. The method of claim 14, wherein the method comprises administering the composition via subcutaneous injection to the subject. 20. A composition comprising a compound of formula III-1: wherein the composition is substantially free of tungsten, and wherein the composition comprises less than 190 ppm of a compound of formula II-1:

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.